taperin Inhibitors
Chemical inhibitors of taperin can disrupt its function through various mechanisms by targeting different aspects of cellular physiology. Ouabain and digoxin, for instance, specifically inhibit the Na⁺/K⁺-ATPase pump, which is crucial for maintaining the electrochemical gradient across cell membranes. Taperin, being an integral membrane protein, relies on these gradients for proper function. When the activity of this ion pump is inhibited, the resulting ionic imbalance can lead to dysfunction of taperin by altering the cellular environment it requires for activity. Similarly, brefeldin A and monensin disrupt intracellular organelles and ion gradients, respectively. Brefeldin A's ability to inhibit the function of the Golgi apparatus impedes the proper folding and trafficking of taperin. Monensin acts as an ionophore that alters intracellular pH and sodium concentrations, which can affect taperin's trafficking and localization, leading to its functional inhibition.
Chemicals like thapsigargin and cyclopiazonic acid inhibit SERCA pumps, leading to a decrease in intracellular calcium stores, which are essential for various signaling pathways and the function of proteins like taperin. Tunicamycin's inhibition of N-linked glycosylation can lead to misfolded taperin proteins that are targeted for degradation, preventing them from carrying out their function. Colchicine, by disrupting microtubule polymerization, can inhibit the correct localization of taperin to the plasma membrane. Filipin, which complexes with membrane cholesterol, could disrupt the lipid rafts necessary for the proper localization and function of taperin. Chlorpromazine impedes clathrin-dependent endocytosis, which is essential for the recycling or delivery of taperin to the plasma membrane. Dynasore inhibits dynamin's GTPase activity, crucial for vesicle trafficking, potentially leading to the mislocalization and subsequent functional inhibition of taperin. Lastly, genistein, as a tyrosine kinase inhibitor, can prevent phosphorylation events required for taperin's function, leading to a decrease in its activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain selectively inhibits the Na⁺/K⁺-ATPase pump, which is essential for maintaining the electrochemical gradient across the cell membrane. Inhibition of this pump can lead to altered ionic balances, potentially disrupting cellular processes and signaling pathways that taperin, as an integral membrane protein, may rely on for proper localization and function. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
12β-Hydroxydigitoxin is another cardiac glycoside that inhibits Na⁺/K⁺-ATPase activity. By inhibiting this pump, digoxin would increase intracellular sodium levels, indirectly leading to calcium overload and potentially impairing taperin-dependent signaling or transport mechanisms dependent on calcium homeostasis. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the function of the Golgi apparatus and endoplasmic reticulum, which are crucial for the proper folding and trafficking of membrane proteins like taperin. Disruption of these organelles can inhibit the proper maturation and localization of taperin. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that alters intracellular pH and sodium concentrations. By disrupting these ionic gradients, monensin can affect the trafficking and localization of membrane proteins such as taperin, inhibiting its functional insertion into the membrane. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a potent inhibitor of the sarcoplasmic/endoplasmic reticulum Ca²⁺ ATPase (SERCA). By depleting intracellular calcium stores, thapsigargin can disrupt signaling pathways and cellular processes, possibly leading to a functional inhibition of taperin's activity or localization. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
This compound inhibits SERCA pumps, leading to altered calcium homeostasis. Since calcium signaling is pivotal for numerous cellular processes, including the function of membrane proteins, the inhibition of these pumps could lead to a functional inhibition of taperin. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation in the ER. If taperin undergoes glycosylation for its stability or localization, inhibition of this process by tunicamycin can result in misfolded proteins that are targeted for degradation, thus functionally inhibiting taperin. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine disrupts microtubule polymerization. As microtubules are involved in intracellular trafficking, colchicine could inhibit the correct localization of taperin to the plasma membrane, thereby inhibiting its function. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
Filipin complexes with cholesterol, disrupting lipid rafts within cellular membranes. As taperin is a membrane protein, its localization and function could be dependent on intact lipid rafts, thus filipin could inhibit taperin by altering its membrane environment. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine can disrupt lipid bilayers and inhibit clathrin-dependent endocytosis. This can lead to a functional inhibition of taperin by preventing its proper endocytic recycling or delivery to the plasma membrane. | ||||||